Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05259007Phase 4Unknown
Phase 4, randomised, double-blind trial (3 arms). Primary endpoint: Gastrointestinal Symptom Rating Scale at 14 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05259007.